Menopause at Work: When Workplace Support Isn't an Option

A national research partnership launched in February 2026 between the Society for Women’s Health Research and The Fuchsia Tent is doing something genuinely useful. It is trying to move menopause support from advocacy circles into mainstream business practice. The goal is to produce evidence that speaks to CFOs, frontline managers, male executives, and policymakers. The study, titled Menopause at Work: From Echo Chamber to Mainstream Practice, will release findings in fall 2026. The framing is sharp and the ambition is real.

It will not reach her.

Not the woman this piece is for. Not the senior vice president who has led through three org restructurings and is not about to let a benefits program with her health transition in the title become part of her professional record. Not the partner who built her practice on a reputation for precision and endurance and has no appetite for being seen as someone whose performance requires accommodation. Not the executive who has watched what happens to women who become visible for the wrong reasons in a market-moving performance environment and has decided, quietly and rationally, that she will handle this herself.

She is not in the echo chamber the study is trying to break out of. She was never in it.

The research is designed to persuade organizations to act. That is a very worthy goal. The estimated $26.6 billion in annual employer costs attributed to menopause is a real number, and the case for organizational response is legitimate. Yet the architecture of every proposed solution runs through the employer: benefits audits, manager training, formulary changes and leadership conversation training. Each of these interventions requires the organization to name the problem, and each named program creates a signal, one that feeds directly into what we call Invisible Attrition℠. However well-intentioned, that signal tells anyone paying attention that a woman accessing the service has something to manage.

That signal is the barrier the study does not measure and the frameworks it will produce cannot dissolve.

Research on stigma in this space is consistent: women in performance-driven environments fear that menopause-specific workplace programs may backfire. That singling out the transition reinforces perceptions of diminished capacity, the kind of cognitive changes that are real but misunderstood. That visibility in this particular way carries professional cost. The Fuchsia Tent cites this research directly on its website, and the Society for Women’s Health Research partnership gives the work institutional reach. Together, they name the risk clearly. The gap between naming it and solving it is structural. An employer-facing framework serves employers. A woman who needs something disclosure-independent is simply outside its scope.

What she needs is not a program or a policy. It is a private, structured way to assess what is happening to her performance, protect what she has built, and sustain her capacity through a transition privately. She needs an advisor whose obligation runs exclusively to her: not to her firm’s retention metrics, not to an HR dashboard, not to any reporting relationship she did not choose.

That is a different kind of service, that requires a different kind of expertise. It requires that the advisor understand something the organizational model is not built to accommodate. That for some women, the most important feature of support is discretion and privacy. That is why Lozen Advisory exists.

The fall 2026 release will generate coverage. CFOs and CHROs will be the audience. Some organizations will act and some women will benefit from programs that work for them.

The woman this piece is for will read the coverage, recognize herself in none of it, and keep moving. She may see herself more clearly in how leadership and biology collide quietly than in any policy recommendation.

She does not need to be found by a study. She needs to know that a disclosure-independent path exists, that it was built for exactly her situation, and that the people who built it understood the stakes before they started.

For a closer look at why current workplace research cannot yet measure the condition this article describes, see Who Studies Menopause at Work, and Who Doesn’t.

Lozen Advisory

Lozen Advisory serves professional women navigating personal transitions that affect performance and career continuity, privately and without organizational relationship. If this piece describes your situation, the MAPS Blueprint is where to start.

Book a consultation →